Empatica Health Monitoring Platform
A full-stack health monitoring platform, built on Empatica's legacy of wearable medical technology, real-time data collection and beautifully-designed digital biomarker visualization.
Clinical-quality data from everyday life
One platform, multiple applications
For Clinical Trials
Designed for the patient, enhanced for the scientist
- Develop and monitor digital endpoints using clinical-quality data and validated digital biomarkers
- Provide an easy and intuitive participant experience through a beautiful wearable, automated data collection and in-app troubleshooting
- Access dedicated account management and support
For Academic Research
All the data you need for your next research breakthrough
- Unlock new insights and publish more robust research with high-quality, objective data
- Scale your study across multiple participants, locations and timeframes
- Record multiple short-term sessions across participants from a single device
- Combine raw EDA and PPG sensor data from the medical-grade EmbracePlus
For Clinical Care
Tailor treatments and improve outcomes for Parkinson’s patients
- Access the most comprehensive suite of validated movement disorder algorithms
- Review validated, objective clinical measures in the PKG report
- Understand treatment response in real time for more personalized care
- Ensure patient compliance with the lightweight, discreet EmbraceMini
How the Empatica Health Monitoring Platform works
The Empatica Health Monitoring Platform is a full-stack research suite built on the capabilities of EmbracePlus and entirely created in-house, with dedicated software and cloud infrastructure designed for your real-world and academic research needs.
Empatica devices
EmbracePlus and EmbraceMini continuously measure and record physiological parameters, which are sent via Bluetooth® to a dedicated mobile app
Patient app
The patient app uses the phone’s internet connection to automatically transfer all data to the Empatica Cloud
Empatica Cloud
The Cloud securely stores data and makes it available for review inside the dedicated portal, or for immediate access via direct download
Care Portal
The Care Portal allows you to manage your studies and access your data and digital biomarkers
Technology
EmbracePlus
Empower your research with the most advanced wearable to combine PPG, Accelerometer, Gyroscope, Temperature, and EDA sensors.
More info
EmbraceMini
The world’s smallest actigraphy wearable for clinical trials and clinical care, combining continuous data collection with practicality and power.
More infoData
No black box algorithms
Empatica's devices are able to continuously capture raw data, with no black box algorithms.
Over 300 digital measures to empower your research
Monitor vitals, activity, sleep, and more, thanks to Empatica's wide range of digital measures.
Case studies
Sleep Revolution – diagnosing and treating OSA
Funded by the European Union's Horizon 2020. Empatica has joined a consortium with lead researchers in Obstructive sleep apnea (OSA). The goal of the consortium is to introduce a revolutionary approach based on machine learning to accurately diagnose OSA and provide optimal treatment for patients. With the help of EmbracePlus research suite, researchers and patients from across Europe are brought together under a single platform and work together to reach our common goal.
Monitoring ADHD for optimized treatment
Funded by the European Union’s Horizon 2020. Despite the fact that adult attention-deficit / hyperactivity disorder (ADHD) is a common chronic condition among adults, with a high rate of ADHD patients also presenting various cardiometabolic conditions; our knowledge about this condition is lacking. Empatica has joined this consortium and is providing the EmbracePlus research suite to acquire new and unique real-world data using groundbreaking and advanced technology for continuous health monitoring to help develop ways to monitor ADHD and cardiometabolic symptoms and risks and eventually, contribute to optimized and personalized treatment approaches.
Takeda create a digital biomarker for Fabry Disease diagnosis
Empatica and Takeda collaborated to create a digital biomarker for Fabry Disease, a rare genetic disorder causing severe complications, the most common of which is absent or reduced sweating. Empatica’s EmbracePlus wearable was employed to explore the correlation between Electrodermal Activity (EDA) and sweat patterns. The data was used to develop an algorithm that could accurately distinguish low and high sweating subjects with a sensitivity of 77.27% and a specificity of 75.86%.
